The mortality risk in patients with early onset colorectal cancer: the role of comorbidities
Frontiers in Oncology · 14.04.2023 · 13
DOI: 10.3389/fonc.2023.1139925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 14.04.2023. Verfasst von Shou-Chun Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chi Mei Medical Center, Ministry of Health and Welfare.
Abstract (Originalsprache)
The global incidence of early-onset colorectal cancer (EO-CRC) is increasing. Although the mortality rate is relatively stable, some comorbidities have been associated with a higher mortality rate. This study estimated the mortality risk in patients with EO-CRC with various comorbidities using real-world data to identify the high-risk group using Cox proportional regression for overall and cancer-specific mortality. The incidence rate of EO-CRC significantly increased from 6.04 per 100,000 population in 2007 to 12.97 per 100,000 population in 2017. The five-year overall mortality rate was 101.50 per 1000 person year and the cancer-specific mortality rate was 94.12 per 1000 person year. Patients with cerebrovascular disease (CVD) had a higher mortality risk (hazard ratio (HR): 1.68; 95% confidence interval (CI): 1.25-2.28; p=0.0007). After subgroup analyses based on age, sex, clinical stage, and treatment type, patients with CVD had a higher overall mortality risk compared to non-CVD patients, except for patients undergoing surgery and chemotherapy. Patients with chronic kidney disease had a higher mortality risk in the early clinical stages (HR: 2.31; 95% CI: 1.08-4.96; p=0.0138). Patients who underwent radiotherapy had a higher overall mortality risk (HR: 1.38; 95% CI: 1.04-1.85; p=0.0285) than those without liver disease. Identifying specific comorbidity mortality risks in patients with EO-CRC allows for risk stratification when screening target groups and may lower disease mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
- Department of Medical Research, Chi-Mei Medical Center, Chiali, Tainan, Taiwan.
- Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan.
- Department of Internal Medicine, Chi Mei Medical Center, Chiali, Tainan, Taiwan.
- Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
Förderung
- Chi Mei Medical Center
- Ministry of Health and Welfare
Zitieren
APA
Yu, S. C., Shiue, Y. L., Wu, Y. C., Wang, J. J., Liao, K. M., & Ho, C. H. (2023). The mortality risk in patients with early onset colorectal cancer: the role of comorbidities. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1139925
Vancouver
Yu SC, Shiue YL, Wu YC, Wang JJ, Liao KM, Ho CH. The mortality risk in patients with early onset colorectal cancer: the role of comorbidities. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1139925
BibTeX
@article{Yu2023,
author = {Yu, Shou-Chun and Shiue, Yow-Ling and Wu, Yu-Cih and Wang, Jhi-Joung and Liao, Kuang-Ming and Ho, Chung-Han},
title = {The mortality risk in patients with early onset colorectal cancer: the role of comorbidities},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1139925}
}
EUVIMED